Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Ceder Läkarkonsult AB
AB
Active
Org 5590638259
Sparrgrensgatan 4
Medical specialists activities · NACE 8622
Est. 2016
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,3M
+1661% vs 2024
EBITDA margin
87.7%
+2291% vs 2024
Equity ratio
64.2%
Financial strength
Net profit 2025
SEK 1,6M
+413% vs 2024
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
2M
+200%
2025
Key figures
Annual report 2025
Revenue
SEK 2,3M
+1661%
EBITDA
SEK 2M
+2291%
Net profit
SEK 1,6M
+413%
Total assets
SEK 2,6M
+221%
Equity
SEK 1,6M
+119%
Employees
1
—
Company information
Legal name
Ceder Läkarkonsult AB
Org number
5590638259
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 maj 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Medicinsk konsultverksamhet och handel med värdepapper samt därmed förenlig verksamhet.
Contact
Address
Sparrgrensgatan 4
Email
erikw80@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
0M
2021
0M
2022
0M
2023
0M
2024
2M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
0M
2021
0M
2022
0M
2023
0M
2024
2M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
227
303
339
130
2 289
Staff expenses
—
—
—
—
−169
EBITDA
200
284
302
84
2 008
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
200
284
302
84
2 008
Net financials
—
—
150
308
0
Profit before tax
200
283
452
392
2 008
Tax
−41
−58
−93
−81
−414
Net profit
159
225
359
311
1 595
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
304
418
601
800
2 567
Equity
239
304
443
754
1 649
Long-term debt
0
0
0
0
—
Short-term debt
65
113
158
46
918
Total debt
65
113
158
46
918
Financial ratios
5-year trend
EBITDA margin
87.7%
This company
15.8%
Market median
+455% vs market
2021
2025
Equity ratio
64.2%
This company
38.2%
Market median
+68% vs market
2021
2025
Return on equity
96.7%
This company
18.4%
Market median
+426% vs market
2021
2025
Net profit margin
69.7%
This company
8.1%
Market median
+760% vs market
2021
2025
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
2021
2025
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
EO
Erik Olof Ceder
Deputy Board Member
2022
HE
Hannah Elisabeth Ceder
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Ceder Läkarkonsult AB also hold positions in
0
other companies.
Person
Role here
Other companies
Erik Olof Ceder
Deputy Board Member
0 companies
Hannah Elisabeth Ceder
Board of Directors
0 companies